Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Thioredoxin Systems Logo
Thioredoxin Systems Growth Score
62
CB Rank
123961
Heat Score
3
Thioredoxin Systems develops innovative antibiotic regimen for complicated urinary tract infections.
Founded
obfuscation
PrivateSeries A Solna, Stockholms Lan, Sweden1-10 www.txnsystems.com/
Biotechnology
Life Science
Medical
Overview

Thioredoxin Systems
Total Funding
obfuscation
Growth Score
62
Heat Score
3

Total Funding
obfuscation
obfuscation
Series A raised
obfuscation
Growth Score62
-7 pts
in past quarter
Heat Score 3
-20 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Thioredoxin Systems

CB Rank
123961
Thioredoxin Systems develops innovative antibiotic regimen for complicated urinary tract infections.
Founded
obfuscation
PrivateSeries A Solna, Stockholms Lan, Sweden1-10 www.txnsystems.com/
Biotechnology
Life Science
Medical

Funding Rounds

Series A
OBF
in
obfuscation

Key People

Details

Legal Name Thioredoxin Systems AB
Also Known As TXN Systems
Operating Status Active
Company Type For Profit
Founders  Arne Holmgren
About the Company
Thioredoxin Systems develops innovative antibiotic regimen for complicated urinary tract infections.
Predictions & Insights

Products & Services

EbsArgent™
A combination antibiotic targeting bacterial thioredoxin reductase to treat complicated urinary tract infections, including multidrug-resistant strains.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series A - Thioredoxin Systems Logo
Series A - Thioredoxin Systems
5
obfuscation
— Series A
obfuscation
Series A - Thioredoxin Systems Logo
Series A - Thioredoxin Systems
5
obfuscation
— Series A
obfuscation
Series A - Thioredoxin Systems Logo
Series A - Thioredoxin Systems
5
obfuscation
— Series A
obfuscation
Series A - Thioredoxin Systems Logo
Series A - Thioredoxin Systems
5
obfuscation
— Series A
obfuscation
Series A - Thioredoxin Systems Logo
Series A - Thioredoxin Systems
5
obfuscation
— Series A

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series A - Thioredoxin Systems Logo
Series A - Thioredoxin Systems
5
obfuscation
— Series A
obfuscation
Series A - Thioredoxin Systems Logo
Series A - Thioredoxin Systems
5
obfuscation
— Series A
obfuscation
Series A - Thioredoxin Systems Logo
Series A - Thioredoxin Systems
5
obfuscation
— Series A
obfuscation
Series A - Thioredoxin Systems Logo
Series A - Thioredoxin Systems
5
obfuscation
— Series A
obfuscation
Series A - Thioredoxin Systems Logo
Series A - Thioredoxin Systems
5
obfuscation
— Series A

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Jens Mogensen Logo
Jens Mogensen
—
Series A - Thioredoxin Systems Logo
Series A - Thioredoxin Systems
—
Jens Mogensen Logo
Jens Mogensen
—
Series A - Thioredoxin Systems Logo
Series A - Thioredoxin Systems
—
Jens Mogensen Logo
Jens Mogensen
—
Series A - Thioredoxin Systems Logo
Series A - Thioredoxin Systems
—
Jens Mogensen Logo
Jens Mogensen
—
Series A - Thioredoxin Systems Logo
Series A - Thioredoxin Systems
—
Jens Mogensen Logo
Jens Mogensen
—
Series A - Thioredoxin Systems Logo
Series A - Thioredoxin Systems
—
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 2

Employee Profiles

News

News and Press

News•Nov 1, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

16

IT Spend

$493.1KThis year, Thioredoxin Systems is projected to spend $493.1K on IT, according to Aberdeen.

Active Website Tech Count

20Thioredoxin Systems is actively using 20 technologies for its website, according to BuiltWith. These include Apple Mobile Web Clips Icon, Euro, and  WordPress.

Total IP

8The intellectual property of Thioredoxin Systems includes 5 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery. Additionally, Thioredoxin Systems has registered 3 trademarks with the most popular class being 'Chemical substances', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Thioredoxin Systems's headquarters? Thioredoxin Systems is located in Solna, Stockholms Lan, Sweden.Who invested in Thioredoxin Systems? Thioredoxin Systems has 5 investors including Jens Mogensen and  Mikael Lonn.When was the last funding round for Thioredoxin Systems? Thioredoxin Systems closed its last funding round on
obfuscation
from a Series A round.Who are Thioredoxin Systems's competitors? Alternatives and possible competitors to Thioredoxin Systems may include Merck, Shionogi, and  Aurobindo Pharma.How much funding has Thioredoxin Systems raised to date? Thioredoxin Systems has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(2e7868f 1)
|